Press Releases & Media

Date Title and Summary Additional Formats
Toggle Summary PositiveID's E-N-G Mobile Systems' Announces Incorporation of Advanced Drone Technology
ENG's new drone initiative to enable real-time communication in challenging environments and help deliver market edge
View HTML
Toggle Summary PositiveID's E-N-G Mobile Systems Subsidiary Celebrates 40 Years in Business
ENG has delivered more than 1,500 vehicles to customers around the world and earned more than $5 million in revenue in 2016
View HTML
Toggle Summary PositiveID Announces Highlights for the Third Quarter of 2017
PositiveID's ExcitePCR subsidiary announces new product, the FireflyDX-Portable, with commercial availability scheduled for late 2018 Company Successfully detects Ebola Virus on FireflyDX Prototype System DELRAY BEACH, Fla. , Oct. 09, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID or
View HTML
Toggle Summary PositiveID to Exhibit its Caregiver Non-Contact Thermometer at the Academy of Medical-Surgical Nurses Annual Convention October 12-15th
DELRAY BEACH, Fla. , Oct. 05, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today that its Thermomedics subsidiary will exhibit the Caregiver® non-contact thermometer at the Academy of Medical-Surgical Nurses
View HTML
Toggle Summary PositiveID's E-N-G Mobile Systems' Year-to-Date Bookings Up 152% from Prior Year
DELRAY BEACH, Fla. , Oct. 03, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today that its E-N-G Mobile Systems ("ENG") subsidiary year-to-date vehicle bookings at the end of the third quarter of 2017 increased
View HTML
Toggle Summary PositiveID Subsidiary ExcitePCR Announces Board of Advisors
Dr. R. Paul Schaudies, Charles Pick and Dr. Anilrudh Venugopal bring broad industry expertise and skilled leadership to ExcitePCR to help drive commercialization of FireflyDX
View HTML
Toggle Summary Internal Sample Preparation, Small Size and Rapid Results Differentiate the FireflyDX Systems, says Lyle Probst During BioWatch Panel
Probst's comments were delivered yesterday afternoon during a two-day BioWatch Workshop on "Strategies for Effective Biological Detection Systems" held in Washington, D.C. at the National Academies of Sciences, Engineering, and Medicine. During his presentation, Probst also shared specific scientific data about pathogen detection results delivered by ExcitePCR's FireflyDX technologies
View HTML
Toggle Summary PositiveID's ExcitePCR Subsidiary CEO to Speak on National Academies of Science, Engineering, and Medicine Panel Today
Three-person BioWatch panel on current and future advancements in pathogen detection systems will be held at 3:30 pm in Washington, D.C.
View HTML
Toggle Summary PositiveID's ExcitePCR Subsidiary CEO Lyle Probst Invited to Join Prestigious BioWatch Panel During Two-Day Workshop Hosted by the National Academies of Science, Engineering, and Medicine
Sixty-minute panel about current and future advancements in pathogen detection systems to be held at 3:30 p.m. (ET) on Mon., Sept. 18 at the National Academy of Sciences in Washington, D.C.
View HTML
Toggle Summary PositiveID's ExcitePCR Subsidiary Announces FireflyDX-Portable: A Lightweight, Bookbag-sized, Realtime Pathogen Detection System, with Commercial Availability Slated for Summer 2018
Recent market developments inspire ExcitePCR management to expand its product strategy to a planned rollout of a FireflyDX family of realtime pathogen detection systems, with the FireflyDX-Portable launch scheduled for the summer of 2018 and the FireflyDX-Handheld targeted for availability in 2019
View HTML